| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |